Medications Development for Polydrug Addiction Treatment (R01)

The summary for the Medications Development for Polydrug Addiction Treatment (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Medications Development for Polydrug Addiction Treatment (R01): -Purpose. The National Institute on Drug Abuse (NIDA) is seeking medication discovery and development research grant applications focused on the treatment of patients who are simultaneously addicted to multiple substances, including alcohol, tobacco, illicit drugs and/or prescription drugs. Novel proposals for clinical or preclinical testing of potential medications, as well as relevant animal model development and medicinal chemistry efforts are encouraged. -Mechanism of Support. This FOA will utilize the NIH Research Projects (R01) grant mechanism and runs parallel with a FOA of identical scientific scope, PAS-08-187, that encourages applications under the NIH Exploratory/Developmental (R21) grant mechanism. -Funds Available and Anticipated Number of Awards. During Fiscal Year 2009, the estimated amount of funds available to support projects under this FOA and the parallel R21 FOA (PA-0x-yyy) is $3,000,000. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. Given the likely range of budgets, it is anticipated that 4 to 7 awards could be made during Fiscal Year 2009. The availability of funds and the number of awards in future years will depend upon annual appropriations.

Federal Grant Title:	Medications Development for Polydrug Addiction Treatment (R01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAS-08-186
Type of Funding:	Grant
CFDA Numbers:	93.279
CFDA Descriptions:	Drug Abuse and Addiction Research Programs
Current Application Deadline:	No deadline provided
Original Application Deadline:	Sep 07, 2011
Posted Date:	Jun 26, 2008
Creation Date:	Jun 26, 2008
Archive Date:	Dec 05, 2008
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Native American tribal governments (Federally recognized) Others (see text field entitled "Additional Information on Eligibility" for clarification) Private institutions of higher education City or township governments Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses Public and State controlled institutions of higher education Independent school districts County governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Interven...; • Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory ...; • Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Tr...; • Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship an...; • Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional); • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards; • Drug Abuse Aspects of Hiv/Aids and Other Infections; • Epidemiology of Drug Abuse
More Grants from the National Institutes of Health: • Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not ...; • NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed); • Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional); • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...; • The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Researc...